Diethylpropion
- Generic Name
- Diethylpropion
- Brand Names
- Tepanil
- Drug Type
- Small Molecule
- Chemical Formula
- C13H19NO
- CAS Number
- 90-84-6
- Unique Ingredient Identifier
- Q94YYU22B8
- Background
A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)
- Indication
Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
- Associated Conditions
- Exogenous Obesity
- Associated Therapies
- -
Financial Considerations, Policies for Antiobesity Medication Coverage
US obesity epidemic prompts increased use of antiobesity medications, especially for diabetes management. At AMCP Nexus 2024, experts discussed financial and policy considerations for medication coverage, emphasizing the need for comprehensive, long-term treatment strategies. Despite lifestyle modification challenges, pharmacological therapy is recommended by AGA and ADA, with GLP-1s facing shortages. Monitoring outcomes beyond weight loss and ensuring drug coverage are crucial for effective obesity treatment.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath